Header cover image

Swedish (OMX) Pharma Industry Analysis

UpdatedFeb 03, 2023
DataAggregated Company Financials
Companies40
  • 7D-0.03%
  • 3M-4.5%
  • 1Y-17.1%
  • YTD-1.8%

Last week, the Pharma industry hasn't moved much but Swedencare is up 6.4% in that time. Unfortunately though, the industry is down 17% over the past 12 months. Earnings are forecast to grow by 43% annually.

Industry Valuation and Performance

Has the Swedish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 03 Feb 2023kr47.7bkr7.3b-kr1,966,129,241.00292.9x-24.2x6.5x
Sun, 01 Jan 2023kr48.0bkr7.3b-kr1,910,765,999.00283.1x-25.1x6.6x
Tue, 29 Nov 2022kr50.5bkr7.3b-kr1,876,545,519.00330.1x-26.9x6.9x
Thu, 27 Oct 2022kr49.5bkr7.0b-kr1,754,469,143.0050x-28.2x7.1x
Sat, 24 Sep 2022kr48.9bkr7.0b-kr1,739,821,936.0047x-28.1x7x
Mon, 22 Aug 2022kr53.3bkr6.9b-kr1,783,375,850.0061.4x-29.9x7.7x
Wed, 20 Jul 2022kr49.8bkr6.0b-kr1,414,388,648.0043.2x-35.2x8.3x
Fri, 17 Jun 2022kr50.1bkr5.9b-kr1,509,116,648.0042.9x-33.2x8.5x
Sun, 15 May 2022kr47.8bkr5.6b-kr1,206,911,761.0042.7x-39.6x8.5x
Tue, 12 Apr 2022kr55.3bkr5.5b-kr1,336,664,342.0039.4x-41.4x10x
Thu, 10 Mar 2022kr49.5bkr5.4b-kr1,389,013,613.0030.2x-35.7x9.1x
Sat, 05 Feb 2022kr51.9bkr5.3b-kr1,043,861,217.0091.7x-49.8x9.8x
Mon, 03 Jan 2022kr58.5bkr5.5b-kr1,100,183,162.00125x-53.2x10.7x
Wed, 01 Dec 2021kr56.7bkr5.5b-kr1,097,623,199.00126.2x-51.7x10.4x
Fri, 29 Oct 2021kr54.1bkr4.8b-kr1,581,672,081.00132.9x-34.2x11.3x
Sun, 26 Sep 2021kr55.6bkr4.8b-kr1,582,367,758.00166.1x-35.2x11.6x
Tue, 24 Aug 2021kr54.1bkr4.8b-kr1,413,242,854.26149.5x-38.3x11.3x
Wed, 30 Jun 2021kr54.0bkr4.8b-kr1,412,039,942.26143.4x-38.2x11.3x
Sat, 03 Apr 2021kr50.0bkr4.6b-kr1,468,409,901.50155.1x-34.1x11x
Tue, 05 Jan 2021kr48.2bkr4.5b-kr1,418,962,725.57135.8x-34x10.8x
Fri, 09 Oct 2020kr50.1bkr4.4b-kr913,043,309.1762.2x-54.9x11.4x
Thu, 02 Jul 2020kr40.7bkr4.1b-kr535,762,892.6319.9x-76x9.9x
Sun, 05 Apr 2020kr27.3bkr3.7b-kr436,185,201.6223.5x-62.7x7.3x
Price to Earnings Ratio

-83.4x


Total Market Cap: kr31.9bTotal Earnings: -kr382,446,640.84Total Revenue: kr3.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Pharma Industry Price to Earnings3Y Average -45.8x202120222023
Current Industry PE
  • Investors are pessimistic on the Swedish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 9.7x is higher than the industry's current PS ratio of 6.5x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 30% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market5.10%
Healthcare3.74%
Pharma-0.033%
Pharma-0.033%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SECARE Swedencarekr36.386.4%
+kr346.0m
-65.5%PE39.3x
RLS RLS Globalkr3.169.3%
+kr21.6m
-36.4%PS232.6x
KDEV Karolinska Developmentkr1.912.3%
+kr11.6m
-53.7%PS233.3x
ONCOZ OncoZengekr6.5915.6%
+kr10.4m
-36.0%PB2x
ERMA Enorama Pharmakr8.9015.3%
+kr9.1m
-50.7%PS6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CALTX

kr97.90

Calliditas Therapeutics

7D

-2.3%

1Y

-1.2%

ALZCUR

kr4.36

AlzeCure Pharma

7D

-7.2%

1Y

-31.9%

INDEX

kr0.46

InDex Pharmaceuticals Holding

7D

-35.9%

1Y

-71.9%

ZICC

kr3.12

Ziccum

7D

5.2%

1Y

-56.2%

ORX

kr17.14

Orexo

7D

-3.7%

1Y

-26.2%

RLS

kr3.16

RLS Global

7D

9.3%

1Y

-36.4%

IBT B

kr50.00

Infant Bacterial Therapeutics

7D

-6.0%

1Y

-16.5%

ECTIN B

kr0.96

Ectin Research

7D

18.4%

1Y

-80.0%

CSMED

kr.5.70

CS Medica

7D

-14.6%

1Y

-53.2%

CAMX

kr251.20

Camurus

7D

-0.2%

1Y

92.6%

IRLAB A

kr11.90

IRLAB Therapeutics

7D

-2.9%

1Y

-68.1%

SECARE

kr36.38

Swedencare

7D

6.4%

1Y

-65.5%

KDEV

kr1.91

Karolinska Development

7D

2.3%

1Y

-53.7%

STABL

kr3.85

Stayble Therapeutics

7D

5.2%

1Y

-40.0%

ONCOZ

kr6.59

OncoZenge

7D

15.6%

1Y

-36.0%

ERMA

kr8.90

Enorama Pharma

7D

15.3%

1Y

-50.7%